25 XP   0   0   10

Pmv Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Pmv Pharmaceuticals Inc together

PenkeI guess you are interested in Pmv Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pmv Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pmv Pharmaceuticals Inc

I send you an email if I find something interesting about Pmv Pharmaceuticals Inc.

Quick analysis of Pmv Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Pmv Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.39
Expected worth in 1 year
$3.99
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
$-0.40
Return On Investment
-24.0%

For what price can you sell your share?

Current Price per Share
$1.65
Expected price per share
$1.175 - $2.13
How sure are you?
50%

1. Valuation of Pmv Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$1.65

Intrinsic Value Per Share

$-10.33 - $-11.94

Total Value Per Share

$-5.94 - $-7.55

2. Growth of Pmv Pharmaceuticals Inc (5 min.)




Is Pmv Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$225.6m$269m-$41.1m-18.1%

How much money is Pmv Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$16.6m-$18.3m$1.6m10.0%
Net Profit Margin-243.4%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Pmv Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#237 / 1031

Most Revenue
#558 / 1031

Most Profit
#688 / 1031

Most Efficient
#686 / 1031

What can you expect buying and holding a share of Pmv Pharmaceuticals Inc? (5 min.)

Welcome investor! Pmv Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Pmv Pharmaceuticals Inc.

What can you expect buying and holding a share of Pmv Pharmaceuticals Inc?

First you should know what it really means to hold a share of Pmv Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Pmv Pharmaceuticals Inc is $1.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pmv Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pmv Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.39. Based on the TTM, the Book Value Change Per Share is $-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pmv Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.31-18.6%-0.34-20.3%-0.36-21.6%-0.28-16.7%-0.28-16.7%
Usd Book Value Change Per Share-0.23-14.1%-0.10-6.0%-0.30-18.4%0.2615.6%0.2615.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.23-14.1%-0.10-6.0%-0.30-18.4%0.2615.6%0.2615.6%
Usd Price Per Share3.10-5.07-13.92-17.23-17.23-
Price to Earnings Ratio-2.53--3.78--9.82--17.32--17.32-
Price-to-Total Gains Ratio-13.36--9.73--45.42--74.95--74.95-
Price to Book Ratio0.71-1.15-2.62-2.79-2.79-
Price-to-Total Gains Ratio-13.36--9.73--45.42--74.95--74.95-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.65
Number of shares606
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.100.26
Usd Total Gains Per Share-0.100.26
Gains per Quarter (606 shares)-59.93156.38
Gains per Year (606 shares)-239.71625.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-240-2500626616
20-479-490012511242
30-719-730018771868
40-959-970025022494
50-1199-1210031283120
60-1438-1450037533746
70-1678-1690043794372
80-1918-1930050044998
90-2157-2170056305624
100-2397-2410062556250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%3.013.01.017.6%3.013.01.017.6%3.013.01.017.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%3.013.01.017.6%3.013.01.017.6%3.013.01.017.6%

Fundamentals of Pmv Pharmaceuticals Inc

About Pmv Pharmaceuticals Inc

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Fundamental data was last updated by Penke on 2024-03-22 00:48:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pmv Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pmv Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pmv Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -973.8% means that $-9.74 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pmv Pharmaceuticals Inc:

  • The MRQ is -973.8%. The company is making a huge loss. -2
  • The TTM is -243.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-973.8%TTM-243.4%-730.3%
TTM-243.4%YOY--243.4%
TTM-243.4%5Y-57.3%-186.2%
5Y-57.3%10Y-57.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-973.8%-171.8%-802.0%
TTM-243.4%-205.8%-37.6%
YOY--262.1%+262.1%
5Y-57.3%-455.6%+398.3%
10Y-57.3%-589.0%+531.7%
1.1.2. Return on Assets

Shows how efficient Pmv Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pmv Pharmaceuticals Inc to the Biotechnology industry mean.
  • -6.2% Return on Assets means that Pmv Pharmaceuticals Inc generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pmv Pharmaceuticals Inc:

  • The MRQ is -6.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM-6.6%+0.4%
TTM-6.6%YOY-6.3%-0.3%
TTM-6.6%5Y-5.4%-1.2%
5Y-5.4%10Y-5.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-12.5%+6.3%
TTM-6.6%-12.2%+5.6%
YOY-6.3%-11.2%+4.9%
5Y-5.4%-13.4%+8.0%
10Y-5.4%-14.7%+9.3%
1.1.3. Return on Equity

Shows how efficient Pmv Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pmv Pharmaceuticals Inc to the Biotechnology industry mean.
  • -7.0% Return on Equity means Pmv Pharmaceuticals Inc generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pmv Pharmaceuticals Inc:

  • The MRQ is -7.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.0%TTM-7.3%+0.3%
TTM-7.3%YOY-6.9%-0.5%
TTM-7.3%5Y-5.0%-2.3%
5Y-5.0%10Y-5.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.0%-15.8%+8.8%
TTM-7.3%-15.7%+8.4%
YOY-6.9%-13.9%+7.0%
5Y-5.0%-18.3%+13.3%
10Y-5.0%-19.2%+14.2%

1.2. Operating Efficiency of Pmv Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pmv Pharmaceuticals Inc is operating .

  • Measures how much profit Pmv Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pmv Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of -1,168.2% means the company generated $-11.68  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pmv Pharmaceuticals Inc:

  • The MRQ is -1,168.2%. The company is operating very inefficient. -2
  • The TTM is -292.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,168.2%TTM-292.1%-876.2%
TTM-292.1%YOY--292.1%
TTM-292.1%5Y-68.7%-223.3%
5Y-68.7%10Y-68.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,168.2%-299.1%-869.1%
TTM-292.1%-210.1%-82.0%
YOY--279.7%+279.7%
5Y-68.7%-459.9%+391.2%
10Y-68.7%-596.9%+528.2%
1.2.2. Operating Ratio

Measures how efficient Pmv Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 11.68 means that the operating costs are $11.68 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pmv Pharmaceuticals Inc:

  • The MRQ is 11.682. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.921. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.682TTM2.921+8.762
TTM2.921YOY-+2.921
TTM2.9215Y0.687+2.233
5Y0.68710Y0.6870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6822.861+8.821
TTM2.9213.193-0.272
YOY-3.615-3.615
5Y0.6875.560-4.873
10Y0.6877.396-6.709

1.3. Liquidity of Pmv Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pmv Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 14.78 means the company has $14.78 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pmv Pharmaceuticals Inc:

  • The MRQ is 14.784. The company is very able to pay all its short-term debts. +2
  • The TTM is 18.151. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.784TTM18.151-3.367
TTM18.151YOY23.741-5.590
TTM18.1515Y30.912-12.761
5Y30.91210Y30.9120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7843.986+10.798
TTM18.1514.440+13.711
YOY23.7415.552+18.189
5Y30.9126.158+24.754
10Y30.9126.492+24.420
1.3.2. Quick Ratio

Measures if Pmv Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pmv Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 26.32 means the company can pay off $26.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pmv Pharmaceuticals Inc:

  • The MRQ is 26.319. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 28.927. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ26.319TTM28.927-2.608
TTM28.927YOY37.496-8.569
TTM28.9275Y39.712-10.785
5Y39.71210Y39.7120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ26.3193.638+22.681
TTM28.9274.168+24.759
YOY37.4965.515+31.981
5Y39.7126.012+33.700
10Y39.7126.209+33.503

1.4. Solvency of Pmv Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pmv Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pmv Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Pmv Pharmaceuticals Inc assets are financed with 10.5% credit (debt) and the remaining percentage (100% - 10.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pmv Pharmaceuticals Inc:

  • The MRQ is 0.105. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.097. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.105TTM0.097+0.008
TTM0.097YOY0.081+0.016
TTM0.0975Y0.255-0.158
5Y0.25510Y0.2550.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1050.335-0.230
TTM0.0970.330-0.233
YOY0.0810.267-0.186
5Y0.2550.367-0.112
10Y0.2550.378-0.123
1.4.2. Debt to Equity Ratio

Measures if Pmv Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pmv Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 11.7% means that company has $0.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pmv Pharmaceuticals Inc:

  • The MRQ is 0.117. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.108. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.108+0.009
TTM0.108YOY0.089+0.019
TTM0.1085Y0.062+0.046
5Y0.06210Y0.0620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1170.376-0.259
TTM0.1080.398-0.290
YOY0.0890.334-0.245
5Y0.0620.429-0.367
10Y0.0620.476-0.414

2. Market Valuation of Pmv Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pmv Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Pmv Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -2.53 means the investor is paying $-2.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pmv Pharmaceuticals Inc:

  • The EOD is -1.347. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.530. Based on the earnings, the company is expensive. -2
  • The TTM is -3.775. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.347MRQ-2.530+1.184
MRQ-2.530TTM-3.775+1.245
TTM-3.775YOY-9.823+6.048
TTM-3.7755Y-17.321+13.546
5Y-17.32110Y-17.3210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.347-2.643+1.296
MRQ-2.530-2.418-0.112
TTM-3.775-2.742-1.033
YOY-9.823-4.123-5.700
5Y-17.321-6.257-11.064
10Y-17.321-6.478-10.843
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pmv Pharmaceuticals Inc:

  • The EOD is -1.728. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.246. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.575. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.728MRQ-3.246+1.518
MRQ-3.246TTM-4.575+1.328
TTM-4.575YOY-9.912+5.338
TTM-4.5755Y-19.252+14.677
5Y-19.25210Y-19.2520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.728-3.244+1.516
MRQ-3.246-2.939-0.307
TTM-4.575-3.478-1.097
YOY-9.912-5.592-4.320
5Y-19.252-8.473-10.779
10Y-19.252-8.881-10.371
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pmv Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.71 means the investor is paying $0.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pmv Pharmaceuticals Inc:

  • The EOD is 0.376. Based on the equity, the company is cheap. +2
  • The MRQ is 0.707. Based on the equity, the company is cheap. +2
  • The TTM is 1.145. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.376MRQ0.707-0.331
MRQ0.707TTM1.145-0.439
TTM1.145YOY2.620-1.475
TTM1.1455Y2.791-1.646
5Y2.79110Y2.7910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3762.124-1.748
MRQ0.7072.041-1.334
TTM1.1452.118-0.973
YOY2.6202.915-0.295
5Y2.7913.682-0.891
10Y2.7914.114-1.323
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pmv Pharmaceuticals Inc.

3.1. Institutions holding Pmv Pharmaceuticals Inc

Institutions are holding 99.531% of the shares of Pmv Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Orbimed Advisors, LLC12.58720.40096475291-87786-1.3376
2023-12-31JPMorgan Chase & Co7.64010.00123930340-103381-2.5629
2023-12-31BlackRock Inc6.27830.00033229797-1366581-29.7317
2023-12-31ArrowMark Colorado Holdings, LLC (ArrowMark Partners)5.2760.092927141432443717903.6546
2023-12-31Euclidean Capital LLC5.10780.91682627643-2627643-50
2023-12-31Vanguard Group Inc4.67560.0002240530736298617.7732
2023-12-31Alkeon Capital Management, LLC4.55910.01622345361-2053-0.0875
2023-09-30Citadel Advisors Llc3.73680.00251922357-204464-9.6136
2023-12-31Woodline Partners LP3.48260.0604179155370081364.2512
2023-09-30InterWest Venture Management Co3.139248.0506161491100
2023-12-31Goldman Sachs Group Inc3.12140.0005160575066225970.1924
2023-12-31Verition Fund Managegment, LLC3.07230.03841580487-885901-35.919
2023-12-31Bank of America Corp2.79890.000514398411290912866.7969
2023-09-30Partner Fund Management LP2.51750.374612951041066694467.0084
2023-09-30OUP Management Co., LLC1.922913.659698923200
2023-09-30Octagon Capital Advisors LP1.75730.852890400043400092.3404
2023-12-31Geode Capital Management, LLC1.67240.0003860336527736.5348
2023-12-31Acadian Asset Management LLC1.49380.00927684497684490
2023-12-31Ghost Tree Capital, LLC1.40930.7348725000191192.7085
2023-12-31State Street Corporation1.40630.0001723454468296.921
Total 77.654865.212839948356+2570742+6.4%

3.2. Funds holding Pmv Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.96340.0002152448700
2023-12-31ArrowMark Small Cap Gro2.34040.5936120396812039680
2023-12-31Meridian Small Cap Growth Legacy2.34040.5908120396812039680
2024-01-31JPMorgan Small Cap Growth A2.21460.05561139280-33308-2.8406
2024-02-29iShares Russell 2000 ETF1.79460.0027923226-151-0.0164
2024-01-31JPM Global Healthcare C (acc) USD1.7370.0342893555-822919-47.9424
2023-12-31Federated Hermes MDT Small Cap Core IS1.32470.179681488-80296-10.5405
2023-12-31Federated Hermes MDT SCC Institutional1.32470.1786681488-80296-10.5405
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.05040.00154035182051.5419
2023-12-31Fidelity Small Cap Index0.74090.004738114500
2024-02-01iShares Russell 2000 Value ETF0.71140.00553659654620.1264
2024-01-31BlackRock Advantage Small Cap Core Instl0.5790.014729783700
2023-10-31Goldman Sachs Small Cp Val Insghts Instl0.4840.04542490126367834.3585
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.43860.00122561000
2024-02-29SEI Small Cap Growth F (SIMT)0.43490.119422375000
2024-01-31Fidelity Extended Market Index0.4320.001122222400
2024-01-31JPMorgan Small Cap Blend A0.4240.0282181026080438.6553
2024-02-29Schwab US Small-Cap ETF™0.34120.001917552000
2024-01-31DFA US Micro Cap I0.30140.00415506400
2024-01-31VALIC Company I Small Cap Growth0.29930.046915396900
Total 22.27691.908311460009+1524115+13.3%

3.3. Insider Transactions

Insiders are holding 2.946% of the shares of Pmv Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-22Orbimed Advisors LlcSELL877862.23
2023-09-15Deepika JalotaSELL41046.62

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pmv Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.232-0.099-57%-0.304+31%0.258-190%0.258-190%
Book Value Per Share--4.3874.429-1%5.229-16%4.629-5%4.629-5%
Current Ratio--14.78418.151-19%23.741-38%30.912-52%30.912-52%
Debt To Asset Ratio--0.1050.097+8%0.081+29%0.255-59%0.255-59%
Debt To Equity Ratio--0.1170.108+9%0.089+32%0.062+89%0.062+89%
Dividend Per Share----0%-0%-0%-0%
Eps---0.306-0.335+9%-0.356+16%-0.276-10%-0.276-10%
Free Cash Flow Per Share---0.239-0.275+15%-0.349+46%-0.245+3%-0.245+3%
Free Cash Flow To Equity Per Share---0.233-0.102-56%-0.344+48%0.205-214%0.205-214%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---11.939--------
Intrinsic Value_10Y_min---10.325--------
Intrinsic Value_1Y_max---1.152--------
Intrinsic Value_1Y_min---1.131--------
Intrinsic Value_3Y_max---3.494--------
Intrinsic Value_3Y_min---3.335--------
Intrinsic Value_5Y_max---5.878--------
Intrinsic Value_5Y_min---5.453--------
Market Cap84881775.000-88%159482172.200260691766.800-39%715964911.250-78%886341674.835-82%886341674.835-82%
Net Profit Margin---9.738-2.434-75%--100%-0.573-94%-0.573-94%
Operating Margin---11.682-2.921-75%--100%-0.687-94%-0.687-94%
Operating Ratio--11.6822.921+300%-+100%0.687+1600%0.687+1600%
Pb Ratio0.376-88%0.7071.145-38%2.620-73%2.791-75%2.791-75%
Pe Ratio-1.347+47%-2.530-3.775+49%-9.823+288%-17.321+584%-17.321+584%
Price Per Share1.650-88%3.1005.068-39%13.918-78%17.229-82%17.229-82%
Price To Free Cash Flow Ratio-1.728+47%-3.246-4.575+41%-9.912+205%-19.252+493%-19.252+493%
Price To Total Gains Ratio-7.113+47%-13.364-9.734-27%-45.419+240%-74.946+461%-74.946+461%
Quick Ratio--26.31928.927-9%37.496-30%39.712-34%39.712-34%
Return On Assets---0.062-0.066+6%-0.063+1%-0.054-13%-0.054-13%
Return On Equity---0.070-0.073+5%-0.069-2%-0.050-29%-0.050-29%
Total Gains Per Share---0.232-0.099-57%-0.304+31%0.258-190%0.258-190%
Usd Book Value--225689000.000227820750.000-1%269008500.000-16%238117882.353-5%238117882.353-5%
Usd Book Value Change Per Share---0.232-0.099-57%-0.304+31%0.258-190%0.258-190%
Usd Book Value Per Share--4.3874.429-1%5.229-16%4.629-5%4.629-5%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.306-0.335+9%-0.356+16%-0.276-10%-0.276-10%
Usd Free Cash Flow---12282000.000-14154750.000+15%-17936000.000+46%-12605705.882+3%-12605705.882+3%
Usd Free Cash Flow Per Share---0.239-0.275+15%-0.349+46%-0.245+3%-0.245+3%
Usd Free Cash Flow To Equity Per Share---0.233-0.102-56%-0.344+48%0.205-214%0.205-214%
Usd Market Cap84881775.000-88%159482172.200260691766.800-39%715964911.250-78%886341674.835-82%886341674.835-82%
Usd Price Per Share1.650-88%3.1005.068-39%13.918-78%17.229-82%17.229-82%
Usd Profit---15756000.000-16652000.000+6%-18324750.000+16%-14072941.176-11%-14072941.176-11%
Usd Revenue--1618000.000404500.000+300%-+100%95176.471+1600%95176.471+1600%
Usd Total Gains Per Share---0.232-0.099-57%-0.304+31%0.258-190%0.258-190%
 EOD+3 -5MRQTTM+11 -22YOY+17 -165Y+8 -2510Y+8 -25

4.2. Fundamental Score

Let's check the fundamental score of Pmv Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.347
Price to Book Ratio (EOD)Between0-10.376
Net Profit Margin (MRQ)Greater than0-9.738
Operating Margin (MRQ)Greater than0-11.682
Quick Ratio (MRQ)Greater than126.319
Current Ratio (MRQ)Greater than114.784
Debt to Asset Ratio (MRQ)Less than10.105
Debt to Equity Ratio (MRQ)Less than10.117
Return on Equity (MRQ)Greater than0.15-0.070
Return on Assets (MRQ)Greater than0.05-0.062
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Pmv Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.612
Ma 20Greater thanMa 501.735
Ma 50Greater thanMa 1001.720
Ma 100Greater thanMa 2002.061
OpenGreater thanClose1.640
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -445329-116-212-328-27-355579224
Gross Profit  -16078-82-287-36911-3581,6171,259



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets252,152
Total Liabilities26,463
Total Stockholder Equity225,689
 As reported
Total Liabilities 26,463
Total Stockholder Equity+ 225,689
Total Assets = 252,152

Assets

Total Assets252,152
Total Current Assets207,409
Long-term Assets44,743
Total Current Assets
Cash And Cash Equivalents 38,528
Short-term Investments 165,351
Other Current Assets 3,530
Total Current Assets  (as reported)207,409
Total Current Assets  (calculated)207,409
+/-0
Long-term Assets
Property Plant Equipment 19,048
Long Term Investments 25,505
Long-term Assets Other 190
Long-term Assets  (as reported)44,743
Long-term Assets  (calculated)44,743
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities14,029
Long-term Liabilities12,434
Total Stockholder Equity225,689
Total Current Liabilities
Short-term Debt 852
Accounts payable 3,237
Other Current Liabilities 9,940
Total Current Liabilities  (as reported)14,029
Total Current Liabilities  (calculated)14,029
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt12,434
Long-term Liabilities  (as reported)12,434
Long-term Liabilities  (calculated)12,434
+/-0
Total Stockholder Equity
Retained Earnings -310,003
Accumulated Other Comprehensive Income 224
Other Stockholders Equity 535,468
Total Stockholder Equity (as reported)225,689
Total Stockholder Equity (calculated)225,689
+/-0
Other
Cash and Short Term Investments 203,879
Common Stock Shares Outstanding 51,446
Liabilities and Stockholders Equity 252,152
Net Debt -25,242
Net Invested Capital 225,689
Net Working Capital 193,380
Property Plant and Equipment Gross 22,318
Short Long Term Debt Total 13,286



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-03-31
> Total Assets 
0
0
103,033
0
159,042
374,446
365,531
354,393
355,910
344,178
331,568
315,008
300,564
284,984
270,308
253,960
242,216
261,027
252,152
252,152261,027242,216253,960270,308284,984300,564315,008331,568344,178355,910354,393365,531374,446159,0420103,03300
   > Total Current Assets 
0
0
102,093
86,787
156,757
373,672
364,761
334,953
323,080
313,555
301,286
288,040
281,865
265,176
247,006
233,278
190,413
205,296
207,409
207,409205,296190,413233,278247,006265,176281,865288,040301,286313,555323,080334,953364,761373,672156,75786,787102,09300
       Cash And Cash Equivalents 
0
0
73,278
0
148,021
373,150
361,422
208,783
189,423
176,641
172,467
115,772
87,090
99,850
108,297
142,942
68,209
52,057
38,528
38,52852,05768,209142,942108,29799,85087,090115,772172,467176,641189,423208,783361,422373,150148,021073,27800
       Short-term Investments 
0
0
28,208
0
8,085
0
0
122,706
128,926
131,010
124,696
167,221
190,344
159,007
132,757
86,492
118,878
149,861
165,351
165,351149,861118,87886,492132,757159,007190,344167,221124,696131,010128,926122,706008,085028,20800
       Other Current Assets 
0
0
607
0
651
522
3,339
3,464
4,731
5,904
4,123
4,225
3,609
5,497
5,130
3,022
2,504
2,556
3,530
3,5302,5562,5043,0225,1305,4973,6094,2254,1235,9044,7313,4643,339522651060700
   > Long-term Assets 
0
0
940
0
2,285
774
770
19,440
32,830
30,623
30,282
26,968
18,699
19,808
23,302
20,682
51,803
55,731
44,743
44,74355,73151,80320,68223,30219,80818,69926,96830,28230,62332,83019,4407707742,285094000
       Property Plant Equipment 
0
0
739
609
609
573
569
1,525
12,016
11,804
13,150
14,974
18,391
19,501
20,494
20,368
19,865
19,367
19,048
19,04819,36719,86520,36820,49419,50118,39114,97413,15011,80412,0161,52556957360960973900
       Long Term Investments 
0
0
0
0
0
0
0
16,891
20,613
18,601
16,911
11,773
0
0
2,495
0
31,757
36,184
25,505
25,50536,18431,75702,4950011,77316,91118,60120,61316,8910000000
       Other Assets 
0
0
0
1,706
1,706
201
201
1,024
201
218
221
221
308
307
313
0
181
0
0
0018103133073082212212182011,0242012011,7061,706000
> Total Liabilities 
0
0
173,507
0
5,147
5,476
6,410
6,098
18,063
19,230
23,009
23,165
23,594
23,791
24,280
23,787
24,407
23,415
26,463
26,46323,41524,40723,78724,28023,79123,59423,16523,00919,23018,0636,0986,4105,4765,1470173,50700
   > Total Current Liabilities 
0
0
4,523
5,083
5,053
5,476
6,410
5,796
7,504
8,563
12,219
11,685
11,383
11,656
10,832
10,590
11,447
10,716
14,029
14,02910,71611,44710,59010,83211,65611,38311,68512,2198,5637,5045,7966,4105,4765,0535,0834,52300
       Short-term Debt 
0
0
0
0
0
0
0
666
677
545
403
258
383
394
528
281
18
0
852
8520182815283943832584035456776660000000
       Accounts payable 
0
0
2,837
2,146
2,146
548
1,607
1,252
2,369
1,278
3,189
4,864
3,348
4,826
2,996
1,774
3,489
1,678
3,237
3,2371,6783,4891,7742,9964,8263,3484,8643,1891,2782,3691,2521,6075482,1462,1462,83700
       Other Current Liabilities 
0
0
1,686
0
2,907
4,928
4,803
3,878
4,458
6,740
8,224
6,563
7,652
6,436
7,308
8,535
7,940
9,038
9,940
9,9409,0387,9408,5357,3086,4367,6526,5638,2246,7404,4583,8784,8034,9282,90701,68600
   > Long-term Liabilities 
0
0
168,984
0
94
0
0
302
10,559
10,667
10,790
11,480
12,211
12,135
13,448
13,197
12,960
12,699
12,434
12,43412,69912,96013,19713,44812,13512,21111,48010,79010,66710,55930200940168,98400
       Other Liabilities 
0
0
0
94
94
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000009494000
       Deferred Long Term Liability 
0
0
0
1,505
1,505
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,5051,505000
> Total Stockholder Equity
0
0
-70,474
0
153,895
368,970
359,121
348,295
337,847
324,948
308,559
291,843
276,970
261,193
246,028
230,173
217,809
237,612
225,689
225,689237,612217,809230,173246,028261,193276,970291,843308,559324,948337,847348,295359,121368,970153,8950-70,47400
   Common Stock0000000000000-374,44600000
   Retained Earnings Total Equity000-260,171-241,043-221,698-203,469-186,159-167,726-149,367-134,356-121,482-109,880000000
   Accumulated Other Comprehensive Income 
0
0
-3
0
5
-1,500
0
-13
7
14
-78
-666
-1,023
-1,025
-445
-116
-328
-355
224
224-355-328-116-445-1,025-1,023-666-78147-130-1,50050-300
   Capital Surplus 
0
0
0
0
0
0
469,001
469,790
472,196
474,301
476,363
478,668
481,462
483,916
487,516
490,460
0
0
0
000490,460487,516483,916481,462478,668476,363474,301472,196469,790469,001000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
4,969
5
244,551
469,896
469,001
469,790
472,196
474,301
476,363
478,668
481,462
483,916
487,516
490,460
495,744
532,214
535,468
535,468532,214495,744490,460487,516483,916481,462478,668476,363474,301472,196469,790469,001469,896244,55154,96900



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,257
Gross Profit-1,257-1,257
 
Operating Income (+$)
Gross Profit-1,257
Operating Expense-78,875
Operating Income-80,132-80,132
 
Operating Expense (+$)
Research Development54,628
Selling General Administrative24,247
Selling And Marketing Expenses0
Operating Expense78,87578,875
 
Net Interest Income (+$)
Interest Income9,802
Interest Expense-0
Other Finance Cost-0
Net Interest Income9,802
 
Pretax Income (+$)
Operating Income-80,132
Net Interest Income9,802
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-68,958-91,306
EBIT - interestExpense = -80,132
-68,958
-68,960
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-80,132-68,958
Earnings Before Interest and Taxes (EBITDA)-78,875
 
After tax Income (+$)
Income Before Tax-68,958
Tax Provision-3
Net Income From Continuing Ops-72,549-68,961
Net Income-68,960
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses80,132
Total Other Income/Expenses Net11,174-9,802
 

Technical Analysis of Pmv Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pmv Pharmaceuticals Inc. The general trend of Pmv Pharmaceuticals Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pmv Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pmv Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.81 < 2.11 < 2.13.

The bearish price targets are: 1.5 > 1.46 > 1.175.

Tweet this
Pmv Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pmv Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pmv Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pmv Pharmaceuticals Inc. The current macd is -0.03556857.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pmv Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pmv Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pmv Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pmv Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartPmv Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pmv Pharmaceuticals Inc. The current adx is 12.10.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pmv Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Pmv Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pmv Pharmaceuticals Inc. The current sar is 1.79425242.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pmv Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pmv Pharmaceuticals Inc. The current rsi is 43.61. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Pmv Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartPmv Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pmv Pharmaceuticals Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pmv Pharmaceuticals Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Pmv Pharmaceuticals Inc Daily Stochastic Oscillator ChartPmv Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pmv Pharmaceuticals Inc. The current cci is -77.30382958.

Pmv Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartPmv Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pmv Pharmaceuticals Inc. The current cmo is -15.23848022.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pmv Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartPmv Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pmv Pharmaceuticals Inc. The current willr is -60.52631579.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pmv Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Pmv Pharmaceuticals Inc Daily Williams %R ChartPmv Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pmv Pharmaceuticals Inc.

Pmv Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pmv Pharmaceuticals Inc. The current atr is 0.12537734.

Pmv Pharmaceuticals Inc Daily Average True Range (ATR) ChartPmv Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pmv Pharmaceuticals Inc. The current obv is -4,366,104.

Pmv Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartPmv Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pmv Pharmaceuticals Inc. The current mfi is 31.05.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pmv Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartPmv Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pmv Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

Pmv Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pmv Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.612
Ma 20Greater thanMa 501.735
Ma 50Greater thanMa 1001.720
Ma 100Greater thanMa 2002.061
OpenGreater thanClose1.640
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pmv Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Pmv Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pmv Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pmv Pharmaceuticals Inc

I send you an email if I find something interesting about Pmv Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Pmv Pharmaceuticals Inc.

Receive notifications about Pmv Pharmaceuticals Inc in your mailbox!